Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.
Room3906 Jinmao Tower, 88 Century Boulevard, Shanghai 200121, China
Zhang Ao
Executive Director
Artavazd Arumov Ph.D
Principal
Cyrus Chan
Associate
Nan Chen
Principal
David Chu
Partner
Phil DiGiacomo
Principal
Anna French
Managing Partner
Yuxin Fu
Vice President
Jinda Gao
Principal
Kuantai Yeh
Partner
Robert Headley
Partner
Maykin Ho
Venture Partner
William Hu
Managing Partner
Duane Kuang
Co-Founder and Managing Partner
Nisa Leung
Managing Partner
Dingzheng Li
Vice President
Jing Liu
Vice President
Chang Liu
Associate
Bin Liu
Vice President
Biao Lu
Associate
Shuo Mao
Principal
Will McConnell
Principal
Gary Rieschel
Founder and Managing Partner
James Shen
Venture Partner
Motao Sun
Vice President
Amy Tang
Venture Partner
Yi Tang
Principal
Shiyu Wang
Partner
Rachel Wang
Venture Partner
James Wang
Venture Partner
Jing Wu
Partner
Gillian Xu
RMB funds CFO
Peter (Ming) Yin
Principal, Cleantech
Janet Yu
Partner
Oscar Zhang
Principal
Yafeng Zhou
Associate
Alex Zhou
Partner
Zhiyuan Zhou
Associate
Zhifeng Zhou
Managing Partner
Jing-Shan Hu Ph.D
Venture Partner of Healthcare
Phillip DiGiacomo Ph.D
Principal
Past deals in Series D
IntoCare
Series D in 2024
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.
Zhipu AI
Series D in 2024
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.
SinoUnited Health
Series D in 2024
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.
Xiaoe Tech
Series D in 2024
Xiaoe Tech is a technology service provider specializing in new education solutions. The company offers a range of products, including knowledge payment SaaS, new education SaaS, and enterprise training tools, alongside PaaS cloud services and content distribution solutions. Xiaoe Tech supports content entrepreneurs and educational institutions by providing essential resources such as tools, data, traffic, and talent needed to enhance their operations. Their services facilitate brand communication, traffic growth, classroom teaching, and student management, ultimately aiming to streamline business monetization in the education sector. The company’s focus is on helping clients build and manage their online knowledge platforms effectively, thereby promoting a closed-loop ecosystem for knowledge dissemination.
Wecare Probiotics
Series D in 2023
Wecare Probiotics is a national high-tech enterprise focused on the research and development, production, and application of probiotic strains. The company offers a diverse range of probiotic products, including fermented food strains and beneficial microbial flora, suitable for various industries such as food, healthcare, and medicine. By prioritizing quality and efficiency, Wecare Probiotics aims to deliver effective solutions that meet the needs of its customers.
Huimei Technology
Series D in 2023
Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.
IntoCare
Series D in 2023
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.
Caidya
Series D in 2023
Caidya is a clinical research organization based in North Carolina, founded in 2021. It specializes in providing personalized solutions across various therapeutic areas and aims to enhance the efficiency of clinical trials. Caidya develops a proprietary technology platform that integrates data from multiple systems, offering a near real-time overview of clinical trials. The organization also offers advisory services focused on clinical development plans, regulatory strategies, and approval processes, which support bio-pharmaceutical and medical companies in optimizing their clinical development capabilities. By facilitating the globalization of innovative drugs, Caidya seeks to accelerate the development of medicines and improve the overall success rates of clinical trials.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Ark Biosciences
Series D in 2022
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, focused on discovering and developing therapeutics for unmet medical needs, particularly in respiratory viral infections and viral hepatitis. Founded in 2013, the company is dedicated to addressing global health challenges with its innovative products, which include AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences aims to establish itself as a leader in antiviral drug development through a commitment to scientific excellence and innovation.
Insilico Medicine
Series D in 2022
Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.
Booming Technologies
Series D in 2022
Booming Tech is a cloud-based platform that specializes in game development and virtual reality. It provides tools for creators to design and innovate within virtual environments, catering to various applications, including gaming, industrial simulations, and other immersive experiences. The platform features a robust server architecture that ensures players can engage in real-time, stable interactions regardless of their geographical locations. By focusing on both entertainment and practical applications, Booming Tech supports a diverse range of virtual world creation, enabling users to explore new possibilities in digital interaction.
Shanzhen
Series D in 2021
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.
Petkit
Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd., founded in 2013, specializes in developing and manufacturing innovative pet care products. Based in Shanghai, China, the company offers a diverse range of smart devices designed to enhance the health and well-being of pets. Its product lineup includes smart feeders, antibacterial bowls, drinking fountains, and pet monitoring devices that track activity levels, calorie consumption, and overall health. Additionally, Petkit provides a mobile application that integrates with its smart devices, allowing pet owners to monitor their pets' behaviors and health metrics conveniently. By combining technology with pet care, Petkit aims to simplify pet management for owners while ensuring the welfare of their animals.
NEIWAI
Series D in 2021
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.
Insight Lifetech
Series D in 2021
Insight Lifetech is a medical technology company focused on creating innovative solutions for the diagnosis and treatment of cardiovascular diseases. It has developed a synergistic platform that integrates research and development, manufacturing, and commercialization, which enhances collaboration, accelerates product development, and promotes cost efficiency. The company is notable for creating the first and only domestic fractional flow reserve (FFR) system in China that has received approval from the National Medical Products Administration (NMPA). By manufacturing high-quality medical devices that feature reliable precision diagnostics and therapeutic capabilities, Insight Lifetech aims to empower physicians to improve patient outcomes and save lives.
Xiaoe Tech
Series D in 2021
Xiaoe Tech is a technology service provider specializing in new education solutions. The company offers a range of products, including knowledge payment SaaS, new education SaaS, and enterprise training tools, alongside PaaS cloud services and content distribution solutions. Xiaoe Tech supports content entrepreneurs and educational institutions by providing essential resources such as tools, data, traffic, and talent needed to enhance their operations. Their services facilitate brand communication, traffic growth, classroom teaching, and student management, ultimately aiming to streamline business monetization in the education sector. The company’s focus is on helping clients build and manage their online knowledge platforms effectively, thereby promoting a closed-loop ecosystem for knowledge dissemination.
Hesai Technology
Series D in 2021
Hesai Technology is a company based in Shanghai, China, founded in 2014. It specializes in designing laser radar systems using smart sensing technology. The primary application of these systems is to facilitate autonomous driving by enabling car companies to monitor mixed gas composition and detect hazardous leaks. Additionally, Hesai Technology develops natural gas leak detection systems for industrial processes. Its LiDAR products are used in a variety of applications including advanced driver assistance systems (ADAS), autonomous vehicle fleets, last-mile delivery robots, street sweeping robots, and logistics robots. The company operates through two main segments: the LiDAR segment and the gas detection segment, with the former being the primary revenue generator.
LetsGetChecked
Series D in 2021
LetsGetChecked is a healthcare technology company that facilitates at-home health testing. It connects users with regulated laboratories worldwide for various tests, including general wellness, sexual health, women's health, men's health, and COVID-19. Users collect samples at home using provided kits and mail them back for analysis; results are then accessible online. The platform aims to empower individuals to proactively manage their health, offering services across the United States, Canada, and Europe.
IntoCare
Series D in 2021
IntoCare is a high-tech company specializing in surgical products such as "Smart" powered staplers.
Unisound
Series D in 2021
Beijing Yunzhisheng Information Technology Co., Ltd., also known as Unisound, is a Chinese startup established in June 2012, specializing in intelligent voice and speech processing technologies. The company has developed proprietary speech recognition technologies and utilizes cloud computing to deliver a range of middleware and cloud platforms for speech recognition services. Unisound's offerings cater to both internet enterprises and individual users, providing professional solutions for voice recognition. The core technology team is composed of highly qualified professionals, with over 80% holding doctoral degrees and possessing extensive experience in voice recognition research and development. Additionally, Unisound focuses on Internet of Things (IoT) and artificial intelligence (AI) technologies, enabling efficient communication between users and machines through voice commands, thereby minimizing the need for manual input.
Erwan Technology
Series D in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company offers a variety of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, aimed at equipping users with essential financial skills. With a focus on making financial education accessible, Erwan Technology has reached over 10 million middle-class students across 34 provincial administrative regions, establishing itself as the largest online investment education platform by user base and ranking among the top three platforms by revenue. The company’s mission is to enhance financial literacy by covering topics such as investment strategies, risk management, and wealth management.
Abbisko Therapeutics
Series D in 2021
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
MicroTech Medical
Series D in 2020
MicroTech Medical, established in January 2011 in Hangzhou Future Technical City, focuses on the research, development, manufacturing, and commercialization of diabetes management devices. The company aims to innovate and produce high-tech and affordable medical devices for diabetes care, including both treatment and monitoring solutions. With a significant portion of its revenue generated in China, MicroTech Medical is dedicated to enhancing diabetes management both domestically and globally. The company has received investment from Eli Lilly and Company, which underscores its commitment to advancing diabetes care technology.
Viewtrix Technology
Series D in 2020
Viewtrix Technology specializes in the development of display driver chips and circuit boards, focusing on enhancing display resolution and color representation. The company's technologies support a variety of display types, including LCD, LED, and OLED, making them applicable to mobile phones, tablets, and notebooks. By providing these advanced solutions, Viewtrix Technology enables electronics manufacturers to improve the display quality of their products while also reducing costs.
Yunyinggu
Series D in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.
Asieris Pharmaceuticals
Series D in 2020
Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010, headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris is committed to advancing therapeutic solutions that integrate both diagnosis and treatment, catering to the needs of patients in China and globally. Through its innovative approach, the company seeks to contribute significantly to the fields of oncology and infectious disease management.
InventisBio
Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company specializes in targeted therapies, particularly for lung cancer, breast cancer, and gout. Its product pipeline includes small molecule drug candidates, such as D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in developing novel immuno-oncology therapies that can be used in conjunction with existing treatments like PD-1 antibodies for various cancer types. The company was co-founded by Dr. Yaolin Wang and other scientists with extensive experience in drug discovery at leading pharmaceutical firms, focusing on significant health challenges such as tumors and metabolic disorders.
Delta Medical
Series D in 2020
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
XSKY Data Technology
Series D in 2020
XSKY Data Technology, based in Beijing, specializes in software-defined infrastructure products and services. It offers a range of storage solutions, including XCBS (cloud), XEBS (block), XEUS (unified), XEOS (object), and XEDP (unified data platform), catering to diverse sectors such as finance, enterprise, telecom, energy, and government. XSKY is a significant contributor to the open-source Ceph storage system, ranking top 3 globally. It partners with leading tech companies like Intel and Samsung, providing scalable, cost-effective storage solutions tailored for enterprise data center innovation.
Miaoshou Doctor
Series D in 2020
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Beijing Yuan Xin
Series D in 2020
Beijing Yuanxin is a technology company that offers an integrated healthcare platform for pharmaceutical distribution and health insurance.
New Horizon Health
Series D in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
Club Factory
Series D in 2019
Club Factory operates an online shopping platform that facilitates cross-border e-commerce by connecting consumers directly with manufacturers. The company utilizes big data and artificial intelligence to scan the internet for factories selling products on major platforms like Wish, eBay, and Amazon, allowing it to compare prices from multiple sources. This approach enables Club Factory to present customers with the most competitive pricing options. In addition to enhancing the shopping experience for consumers, the platform also offers supply chain management solutions for enterprises, thereby streamlining the process of purchasing goods at lower prices.
DST Car
Series D in 2019
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a company based in Shenzhen, China, specializing in the rental and maintenance of commercial electric vehicles (EVs) for passenger and cargo transportation. Established in 2015, the company focuses on the transportation and logistics sector, providing sustainable energy vehicle rental services tailored for the new energy logistics market. DiShangTie also manufactures electric car charging stations, supporting its commitment to offering green and sustainable vehicle leasing alternatives to major express logistics and urban distribution companies. Through its services, the company aims to facilitate the adoption of environmentally friendly transport solutions in China.
Shanzhen
Series D in 2019
Shanzhen is a health service platform focused on addressing the physical health and pension needs of individuals born in the 1980s and 1990s. The company provides affordable regular health checkups and personalized health management plans, alongside insurance options. Additionally, Shanzhen offers a range of medical examination services and data finance products aimed at tackling the challenges posed by an aging population and the rising incidence of chronic diseases. By prioritizing the well-being of elderly patients, Shanzhen aims to enhance their quality of life, enabling them to lead happier and healthier lives.
Bondent
Series D in 2019
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
Yi Technology
Series D in 2018
YI Technology is a prominent international developer of advanced imaging technologies, specializing in smart, wearable, and mobile video products. The company is recognized for its innovative contributions to the imaging sector, including the launch of the first action camera capable of recording 4K60 video with extended recording times. YI Technology's product lineup encompasses a variety of devices such as smart home cameras, sports cameras, driving recorders, mirrorless cameras, smart retail boxes, and face capture machines. The company leverages cutting-edge technologies, including computer vision algorithms, deep learning, and advanced face recognition systems, to deliver high-performance, high-quality vision products at competitive prices. Through its focus on intelligent electronic products, YI Technology enables clients to enhance their imaging experiences with sophisticated technology.
AoHua
Series D in 2018
Aohua is a global provider of endoscopy devices and solutions, specializing in the research, development, production, and sales of electronic endoscope equipment as well as endoscopic diagnostic and surgical consumables. Founded in 1994 and based in Shanghai, China, Aohua aims to lead in endoscope technology innovation and advance the progress of endoscopic diagnosis and treatment. The company is committed to enhancing medical practices through its advanced technological offerings in the endoscopy field.
Wacai.com
Series D in 2018
Wacai is a Chinese mobile app developer specializing in personal finance management through its widely-used mobile application. Since its launch in 2009, the app has provided users with bookkeeping services and expanded its functionality to include mutual fund trading in 2013. In 2014, Wacai introduced a credit card manager feature, which has become increasingly popular among users in China. The app aims to help individuals manage their finances effectively by offering tools for personal bookkeeping, credit management, and an online community for financial assistance. With a user base exceeding 40 million, Wacai continues to enhance its platform to meet the evolving needs of its clientele.
Xueba100.com
Series D in 2018
Xueba100 is an educational platform that caters to K-12 students in China, specializing in providing software and online services designed to assist junior and senior high school students with their studies. The platform offers a "super scholar" feature that allows students to upload images of challenging homework questions and receive detailed answers and procedures. This service leverages advanced technology, including STR Technology and deep learning models, to enhance character recognition and improve the accuracy of responses. In addition to its homework assistance, Xueba100 collaborates with experienced instructors to create customized curricula across various subjects, delivering comprehensive educational resources and test preparation tools to support students' learning needs.
Chushou
Series D in 2018
Chushou is a Chinese social networking platform that specializes in live video streaming, primarily focused on mobile gaming. The platform hosts approximately 2.7 million live streaming broadcasters, with around 150,000 active hosts engaging daily. Chushou allows gamers to interact with one another while live streaming their mobile gaming activities, creating a dynamic environment for both broadcasters and viewers. Through its mobile-based services, Chushou facilitates a unique community for gamers, fostering interaction and engagement within the gaming ecosystem.
Mafengwo
Series D in 2017
Mafengwo is a prominent Chinese travel social networking site that facilitates the sharing of travel experiences among users. The platform boasts over one million entries of user-generated travel guides and more than five million ratings and reviews, catering to a diverse array of travel-related needs, including information on hotels, flights, travel routes, visas, and insurance. Since its inception, Mafengwo has served over 25 million users, emphasizing user experience by continually enhancing its social platform for sharing travel information. Its core product, the Travel Guide, encompasses more than 95% of global travel destinations and has surpassed 100 million downloads. In 2012, Mafengwo expanded its offerings by integrating booking services from major platforms such as Booking, Agoda, Ctrip, and eLong, further solidifying its position in the travel industry.
Iron Armour
Series D in 2017
Iron Armour is China TOP 1 online service platform in construction equipment industry. We focus on equipment trading services & equipment management, and we offer diversity choice and service to our customer, which including consignment service, online auction , web portal, and equipment management based on IoT.
Iron Armour
Series D in 2017
Iron Armour, founded in 2009 by CEO Fan Construction, operates a platform dedicated to the sale of second-hand construction machinery. The company aims to facilitate the buying and selling of used equipment, serving users in the engineering machinery sector globally. Iron Armour's platform provides industry information and enables online communication, promoting transparency and access within the market. Committed to enhancing the development of China's construction machinery industry, Iron Armour leverages the internet to connect buyers and sellers, thereby fostering industry progress.
Lagou
Series D in 2017
Lagou.com is a Beijing-based recruitment website that specializes in staffing services, primarily focusing on the technology and internet sectors. Founded in 2013, it provides a platform for job seekers to find employment in various fields, including IT, design, data operations, marketing, sales, and game development. The company has established a strong client base that includes major industry players such as Tencent, Baidu, Alibaba Group, SINA, JD.com, and Beijing Xiaomi Tech. By connecting qualified candidates with leading companies, Lagou.com plays a significant role in facilitating recruitment in China's competitive job market.
ByteDance
Series D in 2017
ByteDance is a technology company that develops and operates a range of content platforms, most notably TikTok and Douyin. It aims to enhance user experiences through innovative technology, allowing individuals to connect, create, and consume content seamlessly. The company specializes in mobile applications that cater to online media, entertainment, and social networking, leveraging artificial intelligence to deliver personalized content that aligns with users' preferences. In addition to its flagship platforms, ByteDance provides tools that facilitate content creation and collaboration, reflecting its commitment to enriching lives through technology.
Zhihu
Series D in 2017
Zhihu is a prominent Chinese social question-and-answer platform that allows users to seek information by soliciting opinions and insights from individuals rather than relying solely on traditional forum responses. Established to foster a community-driven exchange of knowledge, Zhihu has grown significantly, with a registered user base exceeding 300,000 by early 2012. The company operates primarily within the online content community space, monetizing its services through a combination of paid memberships, advertising, content-commerce solutions, and vocational training offerings. All of its revenue is generated from within China, reflecting its focus on the domestic market and its commitment to providing users with a rich and engaging platform for knowledge sharing.
CooTek
Series D in 2017
CooTek is a global mobile internet company founded in 2008 and headquartered in Shanghai, with additional offices in locations such as Silicon Valley and Beijing. The company specializes in developing innovative mobile applications and artificial intelligence technology, aiming to enhance user expression and content engagement. Its flagship product, TouchPal Keyboard, offers a superior input experience for both Android and iPhone users. CooTek's portfolio includes a variety of content-rich applications across multiple categories, including online literature, mobile games, and scenario-based apps in areas such as fitness and healthcare. The company boasts a substantial user base, with its products achieving an average of 213.7 million monthly active users globally in 2018. CooTek is also committed to technology innovation, holding over 170 patents and operating a big data development center and AI lab in Silicon Valley. Additionally, the company actively contributes to academic discourse in the fields of big data and AI, with research presented at prestigious conferences.
Meituan Bike
Series D in 2017
Meituan Bike, previously known as Mobike, is a Chinese bicycle-sharing service that operates a fully station-less model. Founded in January 2015 by Davis Wang Xiao Feng, Hu Wei Wei, and Xia Yi Ping, the company is headquartered in Beijing. Meituan Bike allows users to easily locate and rent bicycles through a mobile application, facilitating convenient transportation for short urban trips. The bicycles are equipped with smart locks and can be reserved via the app, offering a seamless user experience. In April 2018, the company was acquired by Meituan-Dianping for $2.7 billion and was rebranded as Meituan Bike in January 2019 as part of the integration process. The service has grown significantly since its inception, contributing to the development of urban mobility solutions in China.
Shenogen Pharma Group
Series D in 2017
Shenogen Pharma Group is a drug discovery and development company.
OneAPM
Series D in 2016
OneAPM is a Beijing-based provider of IT operation and maintenance management software and services, established in 2008. The company focuses on delivering integrated intelligent solutions aimed at enhancing the operational efficiency of enterprises in China. Its software offerings include real-time performance monitoring for servers and network applications, as well as a comprehensive resource operation and maintenance platform. By providing these tools, OneAPM enables businesses to streamline their system operations and maintenance processes, ultimately leading to improved business performance. The company's mission is to make operation and maintenance more intelligent for its users.
CooTek
Series D in 2016
CooTek is a global mobile internet company founded in 2008 and headquartered in Shanghai, with additional offices in locations such as Silicon Valley and Beijing. The company specializes in developing innovative mobile applications and artificial intelligence technology, aiming to enhance user expression and content engagement. Its flagship product, TouchPal Keyboard, offers a superior input experience for both Android and iPhone users. CooTek's portfolio includes a variety of content-rich applications across multiple categories, including online literature, mobile games, and scenario-based apps in areas such as fitness and healthcare. The company boasts a substantial user base, with its products achieving an average of 213.7 million monthly active users globally in 2018. CooTek is also committed to technology innovation, holding over 170 patents and operating a big data development center and AI lab in Silicon Valley. Additionally, the company actively contributes to academic discourse in the fields of big data and AI, with research presented at prestigious conferences.
Qiniu
Series D in 2016
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches the intelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era.
Shenogen Pharma Group
Series D in 2015
Shenogen Pharma Group is a drug discovery and development company.
LanzaTech
Series D in 2014
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.
MOGU
Series D in 2014
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.
Crown Bioscience
Series D in 2014
Crown Bioscience International, through its subsidiary Crown Bioscience Inc., is a global company specializing in drug discovery and development solutions. Founded in 2006 and based in Taipei, Taiwan, the company focuses on providing translational platforms for oncology, cardiovascular, and metabolic diseases, helping biopharmaceutical companies enhance drug efficacy and patient response while minimizing clinical failures. Crown Bioscience offers a comprehensive range of products, including antibodies for in vivo and in vitro studies, recombinant proteins, and tumor tissue microarrays, as well as integrated preclinical testing services. The firm has established strategic partnerships, including collaborations with the Shanghai Model Organisms Center and Hubrecht Organoid Technology, to advance its capabilities in genetically engineered models and organoid-based preclinical drug development. With facilities in the United States, United Kingdom, China, and Taiwan, Crown Bioscience serves the biotech and pharmaceutical industries worldwide, facilitating the acceleration of new drug development programs.
Novast
Series D in 2011
Novast Holdings Ltd. is a multinational pharmaceutical company with operations in China and the United States, specializing in the research, development, and manufacture of FDA-inspected generic drugs. The company focuses on creating complex formulations that incorporate challenging active pharmaceutical ingredients (APIs) and offers product development services leveraging its expertise in novel technologies and drug delivery systems. Novast has established itself as a prominent player in the pharmaceutical industry in China, possessing unique capabilities in drug development, quality systems, and infrastructure. It collaborates with pharmaceutical and biotechnology companies to bring products to regulated markets, particularly the U.S. market, where it is recognized as a pioneer among Chinese companies selling pharmaceuticals locally. Novast also operates cGMP manufacturing facilities and has a management team experienced in securing numerous generic drug patents in the U.S., alongside independent research and development of innovative drug-delivery technologies.
CITIC Pharmaceutical
Series D in 2009
CITIC Pharmaceutical Co., Ltd. (中信医药) is a pharmaceutical service provider that supplies medicine and related consumables to hospitals. It is a large pharmaceutical operation enterprise integrating medicines supply to hospitals, cross-regional commercial distribution, vaccine sale, medical instruments and consumables sale, and medicine retailing service. In recent years, it has become a pharmaceutical service provider in the supply chain with multiple customized integration service. CITIC Pharmaceutical, which is a subsidiary of CITIC Group, was transformed to a joint venture in 2007. It is invested by China Health System whose holding company is Bioveda China fund and CITIC Investment Holdings Ltd.
ChinaCache
Series D in 2009
ChinaCache is a Chinese provider of content delivery networks and cloud-based services. The company also provides services for many clients in various industries including small and large business enterprises, luxury brands, e-commerce, banking, online gaming, and media. Today, ChinaCache maintains more than 400 service nodes in more than 120 major cities across China and has global points of presence on five continents. Its total network capacity is over 1000Gbps with interconnections to China Telecom, China Netcom, China Mobile, China Unicom, China Railcom, China CERNET, and various other access providers. ChinaCache was established in 1998.
VANCL
Series D in 2008
VANCL is an online retailer based in Beijing, China, specializing in a wide range of apparel, accessories, footwear, and textiles. Founded in 2007 by Chen Nian, the company offers a diverse selection of products, including shirts, dresses, pants, shoes, and various accessories such as bags, scarves, and sunglasses. By focusing on modern styles at competitive prices, VANCL aims to provide customers with high-quality clothing options. In addition to its online presence, the company operates physical stores, enhancing its accessibility to consumers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.